Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.

Polysorbate 20 is a nonionic surfactant commonly used in the formulation of therapeutic monoclonal antibodies (mAb) to prevent protein denaturation and aggregation. It is critical to understand the molecular heterogeneity and stability of polysorbate 20 in mAb formulations as polysorbate can gradually degrade in aqueous solution over time by multiple pathways losing surfactant functions and leading to protein aggregation. The molecular heterogeneity of polysorbate and the interference from proteins and the excipient in the formulation matrix make it a challenge to study polysorbate in protein formulations. In this work, the characterization and stability study of polysorbate 20 in the presence of mAb formulation sample matrix is first reported using two-dimensional liquid chromatography (2DLC) coupled with charged aerosol detection (CAD) and mass spectrometry (MS) detection. A mixed-mode column that has both anion-exchange and reversed-phase properties was used in the first dimension to separate protein and polysorbate in the formulation sample, while polysorbate 20 esters were trapped online and then analyzed using an reversed-phase ultrahigh-performance liquid chromatography (RP-UHPLC) column in the second dimension to further separate the ester species. The MS served as the third dimension to further resolve as well as to identify the polysorbate ester subspecies. Another 2DLC method using a cation-exchange column in the first dimension and the same RP-UHPLC method in the second dimension was developed to analyze the degradation products of polysorbate 20. Stability samples of a protein drug product were studied using these two 2DLC-CAD-MS methods to separate, identify, and quantify the multiple ester species in polysorbate 20 and also to monitor the change of their corresponding degradants. We found different polysorbate esters degrade at different rates, and importantly, the degradation rates for some esters are different in the protein formulation compared to a placebo that has no protein. The multidimensional UHPLC-CAD-MS approach provides insights into the heterogeneous stability behaviors of polysorbate 20 subspecies in real-time stability samples of a mAb formulation.

[1]  B. Kerwin.  Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.

[2]  Y. Kao,et al.  Analysis Methods of Polysorbate 20: A New Method to Assess the Stability of Polysorbate 20 and Established Methods That May Overlook Degraded Polysorbate 20 , 2002, Pharmaceutical Research.

[3]  T. Patapoff,et al.  Single step method for the accurate concentration determination of polysorbate 80 , 1997 .

[4]  R. Neubert,et al.  Towards a molecular characterization of pharmaceutical excipients: mass spectrometric studies of ethoxylated surfactants. , 2006, International journal of pharmaceutics.

[5]  J. Ji,et al.  Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80. , 2011, Journal of chromatography. A.

[6]  A. Blume,et al.  A thermodynamic analysis of the binding interaction between polysorbate 20 and 80 with human serum albumins and immunoglobulins: a contribution to understand colloidal protein stabilisation. , 2009, Biophysical chemistry.

[7]  J L Cleland,et al.  Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.

[8]  K. Dyrstad,et al.  Characterization of polysorbate 80 with liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy: specific determination of oxidation products of thermally oxidized polysorbate 80. , 2012, Journal of pharmaceutical and biomedical analysis.

[9]  Dwight R Stoll,et al.  Comparison of the practical resolving power of one- and two-dimensional high-performance liquid chromatography analysis of metabolomic samples. , 2008, Analytical chemistry.

[10]  Haiyan Zhang,et al.  Quantitative analysis of oleic acid and three types of polyethers according to the number of hydroxy end groups in Polysorbate 80 by hydrophilic interaction chromatography at critical conditions. , 2013, Journal of chromatography. A.

[11]  Y. Kao,et al.  Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection. , 2008, Journal of chromatography. A.

[12]  T. Randolph,et al.  Molten Globule Intermediate of Recombinant Human Growth Hormone: Stabilization with Surfactants , 1996, Biotechnology progress.

[13]  C. Wesdemiotis,et al.  Characterization of polysorbate 85, a nonionic surfactant, by liquid chromatography vs. ion mobility separation coupled with tandem mass spectrometry. , 2014, Analytica chimica acta.

[14]  Theodore W Randolph,et al.  Surfactant-protein interactions. , 2002, Pharmaceutical biotechnology.

[15]  J. Foley,et al.  Reduction in matrix-related signal suppression effects in electrospray ionization mass spectrometry using on-line two-dimensional liquid chromatography. , 2001, Analytical chemistry.

[16]  R. Anderegg,et al.  Two-dimensional SEC/RPLC coupled to mass spectrometry for the analysis of peptides. , 1997, Analytical chemistry.

[17]  A. Gray,et al.  Composition analysis of two batches of polysorbate 60 using MS and NMR techniques. , 2006, Journal of pharmaceutical and biomedical analysis.

[18]  T. Patapoff,et al.  Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear , 2009 .

[19]  F. Ayorinde,et al.  Analysis of some commercial polysorbate formulations using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[20]  D. Matějíček.  Multi heart-cutting two-dimensional liquid chromatography-atmospheric pressure photoionization-tandem mass spectrometry method for the determination of endocrine disrupting compounds in water. , 2012, Journal of chromatography. A.

[21]  M. Powell,et al.  Compendium of excipients for parenteral formulations. , 1998, PDA journal of pharmaceutical science and technology.

[22]  Qian Wang,et al.  On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product. , 2012, Journal of chromatography. A.

[23]  T. R. Bates,et al.  Kinetics of hydrolysis of polyoxyethylene (20) sorbitan fatty acid ester surfactants , 1973, The Journal of pharmacy and pharmacology.

[24]  John Devincentis,et al.  A simple reversed phase high-performance liquid chromatography method for polysorbate 80 quantitation in monoclonal antibody drug products. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  P. Sporns,et al.  Investigating the molecular heterogeneity of polysorbate emulsifiers by MALDI-TOF MS. , 2001, Journal of agricultural and food chemistry.

[26]  Y. J. Wang,et al.  Toward understanding molecular heterogeneity of polysorbates by application of liquid chromatography-mass spectrometry with computer-aided data analysis. , 2011, Analytical chemistry.